Latest Strategy News

Page 181 of 1376
Epsilon Healthcare has achieved its highest quarterly receipts ever with $3.14 million in Q1 2026, driven by strong expansion across contract manufacturing, clinics, and pharmacy operations.
Ada Torres
Ada Torres
30 Apr 2026
Marquee Resources has significantly increased its Mt Clement inferred antimony resource and is advancing drilling and strategic partnerships to develop its flagship project.
Maxwell Dee
Maxwell Dee
30 Apr 2026
Beonic Limited’s Q3 FY26 results highlight a tripling of EBITDA margin to 15.8%, driven by operational leverage and gross margin expansion, while the Moroccan Airports rollout stays on track for full delivery by June 2026.
Sophie Babbage
Sophie Babbage
30 Apr 2026
Future Metals has trimmed pre-production capital for its Panton PGM Project by approximately A$74 million through an independent engineering assessment of the Savannah processing facility. Further savings are possible by shifting crushing and ore sorting to Panton, while rising platinum group metal prices bolster project economics.
Maxwell Dee
Maxwell Dee
30 Apr 2026
Pointerra Limited delivered a 214% jump in Q3 FY26 customer receipts to A$2.2 million, driven by milestone invoicing and new Tier 1 utility contracts, edging closer to operating cashflow breakeven.
Sophie Babbage
Sophie Babbage
30 Apr 2026
Cyprium Metals has made substantial progress on its Nifty Copper Complex restart, targeting copper cathode production by September 2026 while securing A$41 million to fuel exploration and growth.
Maxwell Dee
Maxwell Dee
30 Apr 2026
Encounter Resources (ASX:ENR) has reported a major 83% increase in the Green deposit’s inferred niobium resource at its Aileron project, lifting the combined inferred mineral resource by 54%. Meanwhile, copper-gold drilling advances in the Paterson Province as the company targets Havieron-style systems.
Maxwell Dee
Maxwell Dee
30 Apr 2026
Adavale Resources reports strong assays from initial drillholes at London-Victoria, revealing high-grade northern lodes and broad southern mineralisation that underpin resource growth potential.
Maxwell Dee
Maxwell Dee
30 Apr 2026
Rhythm Biosciences marked a pivotal shift from development to commercial diagnostics in Q3 FY26, recording its first ColoSTAT® clinical sale and initiating NHS England evaluation while expanding geneType™ partnerships across Asia and Australia.
Ada Torres
Ada Torres
30 Apr 2026
Pivotal Metals has kicked off drilling at its Belleterre projects and reported promising metallurgical testwork at Horden Lake, supporting an upcoming resource update and scoping study.
Maxwell Dee
Maxwell Dee
30 Apr 2026
Green360 Technologies has kicked off commercial production of its low-carbon Eco-Clay cement alternative through a capital-light tolling agreement with Calix, while securing federal grant funding and a $4.5 million placement to fuel growth.
Maxwell Dee
Maxwell Dee
30 Apr 2026
Bellavista Resources has secured an 80% stake in the high-grade Pickle Crow Gold Project in Ontario, backed by a two-tranche A$35 million placement. The company also advanced bioleaching research at its Brumby Project, signalling diversified exploration progress.
Maxwell Dee
Maxwell Dee
30 Apr 2026